Clongen Laboratories, LLC XMRV test
http://clongen.com/XMRV_PCR_Testing.php?gclid=CK-s_PSMo58CFSgVagodb1L1_g
$375 per sample
http://clongen.com/XMRV_PCR_Testing.php?gclid=CK-s_PSMo58CFSgVagodb1L1_g
$375 per sample
On an interesting page about the CEO and founder Ahmed KilaniDated January 30th 2008
source: http://www.morgellons-uk.net/?p=335
Clongen Laboratories
Based on the structures that we observed microscopically from a number of Morgellons patients and the clinical profiles, we have reasons to believe that this organism is not a virus or bacteria. We hypothesize that this organism is a more complex fungus, algae or a novel parasite. The fibers are most likely feeding structures as they have strong resemblance to aerial hyphae observed in many fungal species. Our research is focused on genetic investigations of the DNA in lesions and fibers. Our experiments will include assays that attempt to amplify any bacterial sequences and identify them by DNA sequencing if present to rule out or confirm that the organism is a bacteria as other investigators have hypothesized.
They are also listed as a lab of choice for the Lyme foundationThe Morgellons Research Foundation wants to thank Ahmed Kilani, Ph.D., the president of Clongen Laboratories. Dr. Kilani is a microbiologist who learned about Morgellons from someone suffering from the disease and decided to help. He has been volunteering his spare time and his lab to perform this research because he truly cares. We want to thank Dr. Kilani for all of his efforts. You can find information about Dr. Kilani's Morgellons research at his website www.clongen.com.
Ahmed Kilani, Ph.D., President and Laboratory Director: The company was founded by Dr. Ahmed Kilani in 1999 in Mountain View, California. Dr. Kilani registered the company in California and conducted business as a Biotechnology Consulting Firm. Dr. Kilani holds a Bachelor degree in Medical Technology, a Masters in Clinical Science (San Francisco State University) and a Ph.D. in Infectious Diseases and Immunity (University of California at Berkeley, 1999). He is also board certified nationally (American Society of Clinical Pathologists - ASCP) and in California (Clinical Laboratory Scientist - CLS/MT). Dr. Kilani has extensive experience in Microbiology, Virology, Molecular and Cell Biology. The laboratory facility in Germantown, MD was established in 2004. The company consists of two main divisions: Clinical Diagnostics for Infectious Diseases and Contract Research. We hold state and national licenses in laboratory medicine (CLIA-Certified). Dr. Kilani can be contacted at 301-916-0173 (Ext 204) (877-CLONGEN) or by e-mail at akil@clongen.com.
They cover a lot of ground for 4 little ol' employees!Activity:- Clinical TrialsProduct / Technology type(s) covered:
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution
- BioTherapeutic targets:
- Devices
- Diagnostics
- Drug delivery
- FP (finished products)
- Preventive
- Reagents
- Technology
- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Infectious Diseases
Company ContactClongen Laboratories, LLC
12321 Middlebrook Road, Suite 120
20874 Germantown
MD
United States of America
Phone: 301-916-0173
FAX: 301-916-0175
Website: http://www.clongen.com
Send an email
Markets Covered
a. HeadQuarter: United States of America
b. Continent(s) active: North America , Europe , Australia/New-Zealand , Near/Middle East , Africa , Asia
c. Countries active: USA, Canada, France, Britain, Italy, Australia, New ZEaland, Middle East
Corporate data:
Number of Employees: 4
Hi,
Been reading some of the threads here in the last few days. I want to say that I don't expect much from this test, for various reasons (in general, it seems like for now only the VIPDx is doing the necessary steps in order to find XMRV if it's there, and even this diagnosis might miss it, i think). The main reason for now is, that as I remember, according to WPI (I don't remember if it's Dr. Lombardi or VIPDx which is connected to him, or another person from the WPI) 20 ml of blood are necessary for the test. this lab requires only "at least 1 ml of whole blood". Cooperative Diagnostics requires only a drop of blood - and we can see that there are no positives here in the poll regarding their test. So maybe we really do need 20 mililiters?
For me, it's very easy: there are two labs that's been offering XMRV test for a while, with different techniques in each test, and two studiies that tried finding XMRV, with different techniques in each one.Different types of PCR test require different sample sizes. Some real-time PCR tests really do only require small amounts of whole blood, which could be gained even from a drop of blood (on the right type of collection paper). WPI/VIP is using an older standard PCR method that apparently requires more blood.
But all that said, there are some questions about PCR testing for the virus WPI found, apparently WPI is backing away from PCR testing now, per their Facebook post today. Hard to say what that really means.